Gastrointestinal Special Issue | CURE

Every Patient Who Has a GI Cancer Should Be Tested for MSI-High Status

April 05, 2018

Editor's Page

With immunotherapy continuing to command headlines in the world of oncology, it’s no surprise that patients with a variety of cancers wonder whether the strategy might help them address and overcome their illnesses.

Chemo Regimen Helps Control Locally Advanced Pancreatic Cancer

March 23, 2018

Conference Coverage

“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.

Immunotherapy After Targeted Drug Shows Promise in Advanced Liver Cancer

March 22, 2018

Conference Coverage

Treatment with the PD-1 inhibitor Keytruda (pembrolizuumab) elicited promising progression-free survival (PFS) and overall survival (OS) results in patients with advanced hepatocellular carcinoma (HCC) who received previous treatment with Nexavar (sorafenib), according to phase 2 findings.